Literature DB >> 20012975

[Pathogenesis and diagnosis of Sjögren's syndrome].

T Witte1.   

Abstract

Sjögren's syndrome is a common autoimmune disorder. Several genetic risk factors such as STAT-4, ILT6 and the haplotype HLA-B8/DR3 have been identified. In addition, there are environmental risk factors, possibly chronic viral infections. In the pathophysiology of Sjögren's syndrome T and B cells infiltrate the salivary and lacrimal glands. As a consequence of the destruction of glandular cells by cytotoxic T cells, production of cytokines and autoantibodies inhibiting glandular function, the production of saliva and tears is decreased. The feeling of dry eyes and mouth is frequently not noticed by the patients. Therefore, Sjögren's syndrome should also be considered when extraglandular manifestations such as vasculitis, polyneuropathy or arthritis occur, even when the patients do not complain of dry eyes and mouth. Establishing the diagnosis of Sjögren's syndrome requires verification of reduced glandular function, for example using Schirmer's test and the Saxon test. The confirmation of Sjögren's syndrome as a cause of sicca syndrome is subsequently performed by the detection of autoantibodies against Ro (SS-A) and La (SS-B) and/or by a salivary gland biopsy.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20012975     DOI: 10.1007/s00393-009-0519-2

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  26 in total

Review 1.  Classification criteria for Sjögren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group.

Authors:  C Vitali; S Bombardieri; R Jonsson; H M Moutsopoulos; E L Alexander; S E Carsons; T E Daniels; P C Fox; R I Fox; S S Kassan; S R Pillemer; N Talal; M H Weisman
Journal:  Ann Rheum Dis       Date:  2002-06       Impact factor: 19.103

Review 2.  Clinical manifestations and early diagnosis of Sjögren syndrome.

Authors:  Stuart S Kassan; Haralampos M Moutsopoulos
Journal:  Arch Intern Med       Date:  2004-06-28

3.  Dry eyes or mouth--an epidemiological study in Swedish adults, with special reference to primary Sjögren's syndrome.

Authors:  L T Jacobsson; T E Axell; B U Hansen; V J Henricsson; A Larsson; K Lieberkind; B Lilja; R Manthorpe
Journal:  J Autoimmun       Date:  1989-08       Impact factor: 7.094

4.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

5.  Diagnostic value of sialography with both the conventional and digital subtraction techniques in children with primary and secondary Sjögren's syndrome.

Authors:  M Stiller; W Golder; E Döring; K Kliem
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1999-11

6.  Scintigraphic features of chronic sialadenitis and Sjögren's syndrome: a comparison.

Authors:  G A Hermann; F B Vivino; J E Goin
Journal:  Nucl Med Commun       Date:  1999-12       Impact factor: 1.690

7.  Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.

Authors:  Fang Wang; Michael W Jackson; Vicki Maughan; Dana Cavill; Anthony J Smith; Sally A Waterman; Tom P Gordon
Journal:  Arthritis Rheum       Date:  2004-11

8.  Treatment of sicca symptoms with hydroxychloroquine in patients with Sjogren's syndrome.

Authors:  Markus Rihl; Kai Ulbricht; Reinhold E Schmidt; Torsten Witte
Journal:  Rheumatology (Oxford)       Date:  2009-05-11       Impact factor: 7.580

9.  Activation of IFN pathways and plasmacytoid dendritic cell recruitment in target organs of primary Sjögren's syndrome.

Authors:  Jacques-Eric Gottenberg; Nicolas Cagnard; Carlo Lucchesi; Franck Letourneur; Sylvie Mistou; Thierry Lazure; Sebastien Jacques; Nathalie Ba; Marc Ittah; Christine Lepajolec; Marc Labetoulle; Marc Ardizzone; Jean Sibilia; Catherine Fournier; Gilles Chiocchia; Xavier Mariette
Journal:  Proc Natl Acad Sci U S A       Date:  2006-02-13       Impact factor: 11.205

10.  Increased salivary gland tissue expression of Fas, Fas ligand, cytotoxic T lymphocyte-associated antigen 4, and programmed cell death 1 in primary Sjögren's syndrome.

Authors:  Anne Isine Bolstad; Hans Geir Eiken; Benedikte Rosenlund; Marta E Alarcón-Riquelme; Roland Jonsson
Journal:  Arthritis Rheum       Date:  2003-01
View more
  3 in total

1.  [Sensory neuronopathy of Sjögren's syndrome. A diagnostic challenge].

Authors:  D Czell; R Baldinger; W Jochum; M Weber
Journal:  Nervenarzt       Date:  2012-02       Impact factor: 1.214

2.  Serologic features of primary Sjögren's syndrome: clinical and prognostic correlation.

Authors:  Mario García-Carrasco; Claudia Mendoza-Pinto; César Jiménez-Hernández; Mario Jiménez-Hernández; Arnulfo Nava-Zavala; Carlos Riebeling
Journal:  Int J Clin Rheumtol       Date:  2012-12

3.  [Differential diagnosis of inflammatory arthritis of the hip joint].

Authors:  A Jablonka; R E Schmidt; D Meyer-Olson
Journal:  Unfallchirurg       Date:  2012-11       Impact factor: 1.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.